Reducing the load: The evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation

Kymberly D. Watt

Research output: Contribution to journalArticle

15 Scopus citations

Abstract

Key Points 1. Obesity is common in patients with end-stage liver disease of any cause. 2. Obesity is associated with comorbidities that can affect liver transplant candidacy, such as metabolic syndrome (diabetes, hyperlipidemia, and hypertension), cardiovascular disease, pulmonary disorders (related to obstructive sleep apnea), renal dysfunction, and malignancies. 3. Nonalcoholic steatohepatitis is the only indication for transplantation that is increasing in frequency, and it may soon become the leading indication. 4. There is no set body mass index above which liver transplantation is contraindicated. Transplant candidacy and outcomes depend on the cumulative comorbidities of the individual patient. 5. Weight loss is an important component of metabolic syndrome management and is recommended before liver transplantation. 6. Bariatric surgery may be considered in carefully selected patients with well-compensated cirrhosis but is not recommended in patients with decompensated cirrhosis.

Original languageEnglish (US)
Pages (from-to)S52-S58
JournalLiver Transplantation
Volume18
Issue numberSUPPL.2
DOIs
StatePublished - Nov 1 2012

    Fingerprint

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation

Cite this